EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exosomes in Precision Oncology and Beyond: From Bench to Bedside in Diagnostics and Therapeutics

Emile Youssef iD, Dannelle Palmer, Brandon Fletcher, Renee Vaughn

Cancers · 10.03.2025 · 17 (6) · 940

DOI: 10.3390/cancers17060940 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 10.03.2025. Verfasst von Emile Youssef und 3 weiteren Autor:innen. Beteiligte Einrichtung: Kapadi, Inc., Raleigh, NC 27615, USA. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 264 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Exosomes have emerged as pivotal players in precision oncology, offering innovative solutions to longstanding challenges such as metastasis, therapeutic resistance, and immune evasion. These nanoscale extracellular vesicles facilitate intercellular communication by transferring bioactive molecules that mirror the biological state of their parent cells, positioning them as transformative tools for cancer diagnostics and therapeutics. Recent advancements in exosome engineering, artificial intelligence (AI)-driven analytics, and isolation technologies are breaking barriers in scalability, reproducibility, and clinical application. Bioengineered exosomes are being leveraged for CRISPR-Cas9 delivery, while AI models are enhancing biomarker discovery and liquid biopsy accuracy. Despite these advancements, key obstacles such as heterogeneity in exosome populations and the lack of standardized isolation protocols persist. This review synthesizes pioneering research on exosome biology, molecular engineering, and clinical translation, emphasizing their dual roles as both mediators of tumor progression and tools for intervention. It also explores emerging areas, including microbiome–exosome interactions and the integration of machine learning in exosome-based precision medicine. By bridging innovation with translational strategies, this work charts a forward-looking path for integrating exosomes into next-generation cancer care, setting it apart as a comprehensive guide to overcoming clinical and technological hurdles in this rapidly evolving field.

Schlagwörter

Stichwörter der Autor:innen

biomarkerscancer diagnosticsdrug deliveryexosomesextracellular vesicles (EVs)immune modulationliquid biopsiesprecision medicinetherapeutic resistancetumor microenvironment (TME)tumor-derived exosomes (TDEs)

Autor:innen und Institutionen

  • Kapadi, Inc., Raleigh, NC 27615, USA.

ORCID-Profile: Emile Youssef

Zitieren

APA

Youssef, E., Palmer, D., Fletcher, B., & Vaughn, R. (2025). Exosomes in Precision Oncology and Beyond: From Bench to Bedside in Diagnostics and Therapeutics. Cancers, 17(6), 940. https://doi.org/10.3390/cancers17060940

Vancouver

Youssef E, Palmer D, Fletcher B, Vaughn R. Exosomes in Precision Oncology and Beyond: From Bench to Bedside in Diagnostics and Therapeutics. Cancers. 2025;17(6):940. doi:10.3390/cancers17060940

BibTeX
@article{Youssef2025,
  author = {Youssef, Emile and Palmer, Dannelle and Fletcher, Brandon and Vaughn, Renee},
  title = {Exosomes in Precision Oncology and Beyond: From Bench to Bedside in Diagnostics and Therapeutics},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {6},
  pages = {940},
  doi = {10.3390/cancers17060940}
}
Kostenlos starten →